SYNTEKABIO

The current price of 226330 is 10550 KRW — it has decreased by 0.85% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SYNTEKABIO stocks are traded under the ticker 226330.

226330 stock is 2.97% volatile and has beta coefficient of 1.02. Check out the list of the most volatile stocks — is SYNTEKABIO there?

Yes, you can track SYNTEKABIO financials in yearly and quarterly reports right on TradingView.

226330 stock has risen by 2.13% compared to the previous week, the month change is a 3.21% fall, over the last year SYNTEKABIO has showed a 35.26% increase.

226330 net income for the last quarter is ‪−13.42 B‬ KRW, while the quarter before that showed ‪6.30 B‬ KRW of net income which accounts for −313.09% change. Track more SYNTEKABIO financial stats to get the full picture.

No, 226330 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 226330 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNTEKABIO stock right from TradingView charts — choose your broker and connect to your account.

226330 reached its all-time high on Oct 5, 2020 with the price of 48700 KRW, and its all-time low was 5010 KRW and was reached on Mar 19, 2020.
See other stocks reaching their highest and lowest prices.

As of Apr 24, 2024, the company has 54.00 employees. See our rating of the largest employees — is SYNTEKABIO on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNTEKABIO technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNTEKABIO stock shows the sell signal. See more of SYNTEKABIO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNTEKABIO EBITDA is ‪−10.73 B‬ KRW, and current EBITDA margin is ‪−8.73 K‬%. See more stats in SYNTEKABIO financial statements.